Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe

NCT06203119 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT06203119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06203119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Phase 1
Overall status
Completed
Start date
March 6, 2024
Completion date
December 18, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer